<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the potential neuroprotective effects of combination treatment with normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> (NBO) and <z:chebi fb="0" ids="31530">edaravone</z:chebi>, a potent scavenger of <z:chebi fb="1" ids="29191">hydroxyl radicals</z:chebi>, on <z:hpo ids='HP_0011009'>acute</z:hpo> brain injuries after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Mice subjected to 2-h filamental middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> were treated with NBO (95% O2, during the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) alone, with <z:chebi fb="0" ids="31530">edaravone</z:chebi> (1.5 mg/kg, intravenously after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) alone, with both of these treatments (combination), or with vehicle </plain></SENT>
<SENT sid="2" pm="."><plain>The histological and neurological score were assessed at 22-h after reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was significantly reduced in the combination group [36.3+/-6.7 mm3 (n=10) vs. vehicle: 65.5+/-5.9 mm3 (n=14) P&lt;0.05], but not in the two monotherapy-groups [NBO: 50.5+/-5.8 mm3 (n=14) and <z:chebi fb="0" ids="31530">edaravone</z:chebi>: 56.7+/-5.8 mm3 (n=10)] </plain></SENT>
<SENT sid="4" pm="."><plain>The combination therapy reduced TUNEL-positive cells in the ischemic boundary zone both in cortex [6.0+/-1.4 x 10(2)/mm2 (n=5) vs. vehicle: 18.9+/-2.4 x 10(2)/mm2 (n=5), P&lt;0.01] and subcortex [11.6+/-1.5 x 10(2)/mm2 (n=5) vs. vehicle: 22.5+/-2.1 x 10(2)/mm2 (n=5), P&lt;0.01] </plain></SENT>
<SENT sid="5" pm="."><plain>NBO and combination groups exhibited significantly reduced neurological deficit scores at 22-h after reperfusion (vs. vehicle, P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Combination therapy with NBO plus <z:chebi fb="0" ids="31530">edaravone</z:chebi> prevented the neuronal damage after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion in mice, compared with monotherapy of NBO or <z:chebi fb="0" ids="31530">edaravone</z:chebi> </plain></SENT>
</text></document>